Portal de Periódicos da CAPES

Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells

2004; American Society for Microbiology; Volume: 78; Issue: 20 Linguagem: Inglês

10.1128/jvi.78.20.11334-11339.2004

1098-5514

Ling Yi, Zhengquan Li, Kehu Yuan, Xiuxia Qu, Jian Chen, Guangwen Wang, Hong Zhang, Hongpeng Luo, Li Zhu, Pengfei Jiang, Lirong Chen, Yan Shen, Min Luo, Guo‐Ying Zuo, Jianhe Hu, Deliang Duan, Yuchun Nie, Xuanling Shi, Wei Wang, Yang Han, Taisheng Li, Yuqing Liu, Mingxiao Ding, Hongkui Deng, Xiaojie Xu,

Computational Drug Discovery Methods

Severe acute respiratory syndrome coronavirus (SARS-CoV) is the pathogen of SARS, which caused a global panic in 2003. We describe here the screening of Chinese herbal medicine-based, novel small molecules that bind avidly with the surface spike protein of SARS-CoV and thus can interfere with the entry of the virus to its host cells. We achieved this by using a two-step screening method consisting of frontal affinity chromatography-mass spectrometry coupled with a viral infection assay based on a human immunodeficiency virus (HIV)-luc/SARS pseudotyped virus. Two small molecules, tetra-O-galloyl-beta-D-glucose (TGG) and luteolin, were identified, whose anti-SARS-CoV activities were confirmed by using a wild-type SARS-CoV infection system. TGG exhibits prominent anti-SARS-CoV activity with a 50% effective concentration of 4.5 microM and a selective index of 240.0. The two-step screening method described here yielded several small molecules that can be used for developing new classes of anti-SARS-CoV drugs and is potentially useful for the high-throughput screening of drugs inhibiting the entry of HIV, hepatitis C virus, and other insidious viruses into their host cells.